论文部分内容阅读
多因素分析法的临床应用可以帮助医师预测心血管疾病的发病危险并作出治疗决定。然而除了已知和常用的最佳心血管病危险因素评估外,很有可能存在未知的和/或罕见的调节因素在临床冠心病(CHD)的进展中发挥重要作用。冠心病的临床表现通常为亚临床动脉粥样硬化性疾病,实际上亚临床动脉粥样硬化症的检查与定量为所有已知和未知的心血管疾病危险因素的综合分析提供了一种方法,从而也提供了有关临床CHD发展可能性的更加精确的信息。
The clinical application of multivariate analysis can help physicians predict the risk of cardiovascular disease and make treatment decisions. However, in addition to the known and commonly used assessment of the best cardiovascular risk factors, there is a high probability that unknown and / or rare regulatory factors play an important role in the development of clinical coronary heart disease (CHD). The clinical manifestations of coronary heart disease are usually subclinical atherosclerotic disease. Indeed, the examination and quantification of subclinical atherosclerosis provides a method for a comprehensive analysis of all known and unknown cardiovascular risk factors, Thus providing more accurate information about the developmental possibilities of clinical CHD.